L2M – Development of Extracellular Vesicles Isolation Platform via Capillary Microfluidics
This project aims to explore the commercial potential of a new microfluidic device that can isolate tiny particles called extracellular vesicles (EVs) from biological samples. These EVs have important uses in disease detection, drug delivery, and medical research. The goal is to better understand the market, identify customer needs, and develop a plan to bring this technology to real-world users. The expected benefit to the partner organization is a clear commercialization roadmap, stronger understanding of the product’s value, and connections with potential customers and partners to help bring the innovation to market.
Voir la description complète du projetAmir Sanati Nezhad
Innovate Calgary
Life Sciences
Professional, scientific and technical services
University of Calgary
Business Strategy Internship
